Lyme disease history and symptoms: Difference between revisions
No edit summary |
|||
Line 149: | Line 149: | ||
[[image:Symptoms of lyme disease 2001-2015.jpg|center|700px|thumb|Frequency of Lyme disease symptoms, 2001-2015]] | [[image:Symptoms of lyme disease 2001-2015.jpg|center|700px|thumb|Frequency of Lyme disease symptoms, 2001-2015]] | ||
|} | |} | ||
==Erythema migrans== | |||
{| | |||
| | |||
*'''Erythema migrans (EM)''' also known as Erythema chronicum migrans, "bull’s-eye" rash, or Lyme rash develops in around 70% - 80% of patients.<ref name="pmid12802042">{{cite journal| author=Steere AC, Sikand VK| title=The presenting manifestations of Lyme disease and the outcomes of treatment. | journal=N Engl J Med | year= 2003 | volume= 348 | issue= 24 | pages= 2472-4 | pmid=12802042 | doi=10.1056/NEJM200306123482423 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12802042 }} </ref> | |||
**EM is the the pathognomonic rash of Lyme disease. Majority of patients with the rash do not recall tick bite. | |||
**EM begins at the site of a [[tick]] bite after a delay of 3 to 30 days (average is about 7 days). | |||
**EM is classically 5 to 6.8 cm in diameter appearing as an annular homogenous erythema (59%), central erythema (30%), central clearing (9%), or central purpura (2%).<ref name="pmid17113969">{{cite journal| author=Feder HM, Abeles M, Bernstein M, Whitaker-Worth D, Grant-Kels JM| title=Diagnosis, treatment, and prognosis of erythema migrans and Lyme arthritis. | journal=Clin Dermatol | year= 2006 | volume= 24 | issue= 6 | pages= 509-20 | pmid=17113969 | doi=10.1016/j.clindermatol.2006.07.012 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17113969 }} </ref> | |||
**EM gradually expands over a period of days reaching up to 12 inches(30 cm)or more across. | |||
**EM may feel warm to touch but is rarely [[Itch|itchy]] or [[Pain|painful]]. | |||
**EM clears as it enlarges, resulting in a target or “bull’s-eye” appearance. | |||
**EM may appear on any area of the body but majority of times present in areas including [[axilla]], [[inguinal region]], [[popliteal fossa]], or along belt line. | |||
**The [[rash]] does not represent an [[allergic reaction]] to the bite, but rather a [[skin infection]] with the [[Borrelia burgdorferi|Lyme bacteria]], [[Lyme disease microbiology|''Borrelia burgdorferi'' sensu lato]]. | |||
**The characteristic "bull's-eye" rash with central clearing is present in about 20% of endemic cases in the United States; whereas in Europe and the non-endemic United States 80% of rashes have central clearing. In endemic areas of the United States homogeneously red rashes are more frequent.<ref name="pmid11900494">{{cite journal| author=Smith RP, Schoen RT, Rahn DW, Sikand VK, Nowakowski J, Parenti DL et al.| title=Clinical characteristics and treatment outcome of early Lyme disease in patients with microbiologically confirmed erythema migrans. | journal=Ann Intern Med | year= 2002 | volume= 136 | issue= 6 | pages= 421-8 | pmid=11900494 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11900494 }} </ref><ref name="pmid11982300">{{cite journal| author=Edlow JA| title=Erythema migrans. | journal=Med Clin North Am | year= 2002 | volume= 86 | issue= 2 | pages= 239-60 | pmid=11982300 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11982300 }} </ref> | |||
**Serologic testing is not recommended in patients with EM. Initially, majority of patients are seronegative.<ref name="pmid17113969">{{cite journal| author=Feder HM, Abeles M, Bernstein M, Whitaker-Worth D, Grant-Kels JM| title=Diagnosis, treatment, and prognosis of erythema migrans and Lyme arthritis. | journal=Clin Dermatol | year= 2006 | volume= 24 | issue= 6 | pages= 509-20 | pmid=17113969 | doi=10.1016/j.clindermatol.2006.07.012 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17113969 }} </ref> | |||
**Multiple Erythema migrans are present in disseminated disease.<ref name="pmid158674072">{{cite journal| author=Wormser GP, McKenna D, Carlin J, Nadelman RB, Cavaliere LF, Holmgren D et al.| title=Brief communication: hematogenous dissemination in early Lyme disease. | journal=Ann Intern Med | year= 2005 | volume= 142 | issue= 9 | pages= 751-5 | pmid=15867407 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15867407 }}</ref> | |||
**Mini erythema migrans - Sometimes , erythema migrans may be less than 5 cm in diameter. It is an important and atypical sign of early localized [[Lyme disease]].<ref name="pmid16484816">{{cite journal| author=Weber K, Wilske B| title=Mini erythema migrans--a sign of early Lyme borreliosis. | journal=Dermatology | year= 2006 | volume= 212 | issue= 2 | pages= 113-6 | pmid=16484816 | doi=10.1159/000090650 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16484816 }} </ref> | |||
| | |||
<gallery> | |||
Image:Erythema chronicum migrans01.jpg|Erythema chronicum migrans <SMALL><SMALL>''[http://www.atlasdermatologico.com.br/ Adapted from Dermatology Atlas.]''<ref name="Dermatology Atlas">{{Cite web | title = Dermatology Atlas | url = http://www.atlasdermatologico.com.br/}}</ref></SMALL></SMALL> | |||
Image:Bullseye Lyme Disease Rash.jpg|Bulls eye lesion | |||
</gallery> | |||
|} | |||
==Lyme Carditis== | ==Lyme Carditis== | ||
*[[Cardiac]] involvement occurs in about 5—10% of untreated [[Lyme disease]] and patients usually have symptoms related to fluctuating degrees of [[atrioventricular block]] ([[First degree AV block|first-degree block]] to [[complete heart block]]) including [[lightheadedness]], [[palpitations]], [[shortness of breath]], [[chest pain]], and [[syncope]].<ref name="pmid22868858">{{cite journal| author=Hu LT| title=In the clinic. Lyme disease. | journal=Ann Intern Med | year= 2012 | volume= 157 | issue= 3 | pages= ITC2-2 - ITC2-16 | pmid=22868858 | doi=10.7326/0003-4819-157-3-20120807-01002 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22868858 }} </ref> | *[[Cardiac]] involvement occurs in about 5—10% of untreated [[Lyme disease]] and patients usually have symptoms related to fluctuating degrees of [[atrioventricular block]] ([[First degree AV block|first-degree block]] to [[complete heart block]]) including [[lightheadedness]], [[palpitations]], [[shortness of breath]], [[chest pain]], and [[syncope]].<ref name="pmid22868858">{{cite journal| author=Hu LT| title=In the clinic. Lyme disease. | journal=Ann Intern Med | year= 2012 | volume= 157 | issue= 3 | pages= ITC2-2 - ITC2-16 | pmid=22868858 | doi=10.7326/0003-4819-157-3-20120807-01002 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22868858 }} </ref> | ||
*Less commonly, patients may present with an acute picture of [[left ventricular dysfunction]], [[cardiomegaly]], [[perimyocarditis]], or pancarditis without noticeable [[cardiac murmurs]].<ref name="Steere1989">{{cite journal|last1=Steere|first1=Allen C.|title=Lyme Disease|journal=New England Journal of Medicine|volume=321|issue=9|year=1989|pages=586–596|issn=0028-4793|doi=10.1056/NEJM198908313210906}}</ref> | *Less commonly, patients may present with an acute picture of [[left ventricular dysfunction]], [[cardiomegaly]], [[perimyocarditis]], or pancarditis without noticeable [[cardiac murmurs]].<ref name="Steere1989">{{cite journal|last1=Steere|first1=Allen C.|title=Lyme Disease|journal=New England Journal of Medicine|volume=321|issue=9|year=1989|pages=586–596|issn=0028-4793|doi=10.1056/NEJM198908313210906}}</ref> |
Revision as of 21:00, 1 August 2017
Lyme disease Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Lyme disease history and symptoms On the Web |
American Roentgen Ray Society Images of Lyme disease history and symptoms |
Risk calculators and risk factors for Lyme disease history and symptoms |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Anmol Pitliya, M.B.B.S. M.D.[2], Ilan Dock, B.S.
Overview
Lyme disease is divided into 3 stages and symptoms are stage specific. Initial symptoms include "bulls-eye" rash, with accompanying constitutional symptoms. It can progress to cardiovascular or neurological complications.
History
- The incubation period from infection to the onset of symptoms is usually 1–2 weeks, but can be much shorter (days), or much longer (months to years). Symptoms most often occur from May through September because the nymphal stage of the tick is responsible for most cases. [1]Asymptomatic infection exists, but is uncommon.[2]
- The specific areas of focus when obtaining the history, are outlined below:
Symptoms
Lyme disease is divided into 3 stages and symptoms are stage specific.
- Stage 1 - Early localized disease
- Stage 2 - Early disseminated disease
- Stage 3 - Late disseminated disease
Stage 1 - Early localized disease
Features of early localized disease includes erythema migrans and constitutional symptoms.
|
Stage 2 - Early disseminate disease
Features of early disseminated disease can be divided system wise and includes:
|
- Cardiac manifestations
- Dermatological manifestations[9]
- Borrelial lymphocytoma: Most common site is earlobe.
- Ocular manifestations[10]
- Primary ocular symptoms occurs due to inflammation of ocular tissue. These symptoms includes conjunctivitis, keratitis, iridocyclitis, retinal vasculitis, chorioiditis, and optic neuropathy (extremely rarely episcleritis, panuveitis, panophthalmitis).
- Secondary ocular symptoms occurs due to extraocular manifestations. These symptoms includes pareses of cranial nerves and orbital myositis.
Stage 3 - Late disseminated disease
- Features of late disseminated disease can take months to years to manifest after the onset of infection.
- Lyme arthritis is dominant months later but chronic neurologic involvement becomes more obvious years later.
- The symptoms of late disseminated lyme disease includes:
- Musculoskeletal manifestation:
- Lyme arthritis
- Lyme arthritis is the hallmark of stage 3 Lyme disease.
- Most frequently presented symptom in late disseminated Lyme disease.
- Commonly affects knee joint.
- Lyme arthritis
- Neurological manifestations:
- These neurological symptoms may take months to years to manifest after the infection. In addition to acute symptoms, Neuroborrerliosis can be manifested by a wide-range of neurological disorders, either central or peripheral including:
- Encephalopathy (sub-acute): Affects memory, mood, sleep, and sometimes with subtle language disturbances.
- Polyneuropathy or Paresthesia
- Leukoencephalitis[11]
- Muscle twitching
- Otolaryngologic manifestations: Neck pain, odynophagia, head and neck dysesthesia, otalgia, tinnitus, hearing loss, vertigo, temporomandibular joint pain, lymphadenopathy, dysgeusia.[12][13]
- Neuropsychiatric symptoms often develop much later in the disease progression, much like tertiary neurosyphilis.[14]
- In rare cases, frank psychosis have been attributed to chronic Lyme disease effects, including misdiagnoses of schizophrenia and bipolar disorder.
- Panic attack and anxiety can occur, also delusional behavior, including somatoform delusions, sometimes accompanied by a depersonalization or derealization syndrome similar to what was seen in the past in the prodromal or early stages of general paresis.[15]
- These neurological symptoms may take months to years to manifest after the infection. In addition to acute symptoms, Neuroborrerliosis can be manifested by a wide-range of neurological disorders, either central or peripheral including:
- Dermatological manifestation[9]
- Acrodermatitis chronica atrophicans
- Musculoskeletal manifestation:
|
Erythema migrans
|
|
Lyme Carditis
- Cardiac involvement occurs in about 5—10% of untreated Lyme disease and patients usually have symptoms related to fluctuating degrees of atrioventricular block (first-degree block to complete heart block) including lightheadedness, palpitations, shortness of breath, chest pain, and syncope.[23]
- Less commonly, patients may present with an acute picture of left ventricular dysfunction, cardiomegaly, perimyocarditis, or pancarditis without noticeable cardiac murmurs.[24]
- Lyme carditis can occur independently, it is usually accompanied by other cutaneous, joint, or neurologic features of Lyme disease.[25]
Manifestations of Lyme Disease by Stage
System | Stage 1 (Localized Infection) | Stage 2 (Early Disseminated Infection) | Stage 3 (Late Persistent Infection) |
Skin |
|
| |
Musculoskeletal | — |
|
|
Neurologic | — |
|
|
Lymphatic |
|
|
— |
Heart | — |
|
— |
Eyes | — |
|
|
Liver | — |
|
— |
Respiratory | — |
|
— |
Kidney | — |
|
— |
Genitourinary | — | — | |
Constitutional systems |
Adapted from Steere AC. Lyme disease. N Engl J Med. 1989;321:586.
References
- ↑ Falco RC, McKenna DF, Daniels TJ, Nadelman RB, Nowakowski J, Fish D; et al. (1999). "Temporal relation between Ixodes scapularis abundance and risk for Lyme disease associated with erythema migrans". Am J Epidemiol. 149 (8): 771–6. PMID 10206627.
- ↑ Steere AC, Sikand VK, Schoen RT, Nowakowski J (2003). "Asymptomatic infection with Borrelia burgdorferi". Clin. Infect. Dis. 37 (4): 528–32. PMID 12905137.
- ↑ 3.0 3.1 Steere AC, Sikand VK (2003). "The presenting manifestations of Lyme disease and the outcomes of treatment". N Engl J Med. 348 (24): 2472–4. doi:10.1056/NEJM200306123482423. PMID 12802042.
- ↑ Nadelman RB, Nowakowski J, Forseter G, Goldberg NS, Bittker S, Cooper D; et al. (1996). "The clinical spectrum of early Lyme borreliosis in patients with culture-confirmed erythema migrans". Am J Med. 100 (5): 502–8. PMID 8644761.
- ↑ 5.0 5.1 Wormser GP, McKenna D, Carlin J, Nadelman RB, Cavaliere LF, Holmgren D; et al. (2005). "Brief communication: hematogenous dissemination in early Lyme disease". Ann Intern Med. 142 (9): 751–5. PMID 15867407.
- ↑ Halperin JJ (2008). "Nervous system Lyme disease". Infect Dis Clin North Am. 22 (2): 261–74, vi. doi:10.1016/j.idc.2007.12.009. PMID 18452800.
- ↑ England JD, Bohm RP, Roberts ED, Philipp MT (1997). "Mononeuropathy multiplex in rhesus monkeys with chronic Lyme disease". Ann Neurol. 41 (3): 375–84. doi:10.1002/ana.410410313. PMID 9066359.
- ↑ Chabria SB, Lawrason J (2007). "Altered mental status, an unusual manifestation of early disseminated Lyme disease: A case report". 1 (1): 62. doi:10.1186/1752-1947-1-62. PMID 17688693.
- ↑ 9.0 9.1 Mullegger RR (2004). "Dermatological manifestations of Lyme borreliosis". Eur J Dermatol. 14 (5): 296–309. PMID 15358567.
- ↑ Stanek G, Strle F (2003). "Lyme borreliosis". Lancet. 362 (9396): 1639–47. doi:10.1016/S0140-6736(03)14798-8. PMID 14630446.
- ↑ Halperin JJ, Volkman DJ, Wu P (1991). "Central nervous system abnormalities in Lyme neuroborreliosis". Neurology. 41 (10): 1571–82. PMID 1922798.
- ↑ Rosenhall U, Hanner P, Kaijser B (1988). "Borrelia infection and vertigo". Acta Otolaryngol. 106 (1–2): 111–6. PMID 3421091.
- ↑ Moscatello AL, Worden DL, Nadelman RB, Wormser G, Lucente F (1991). "Otolaryngologic aspects of Lyme disease". Laryngoscope. 101 (6 Pt 1): 592–5. PMID 2041438.
- ↑ Logigian, Eric L.; Kaplan, Richard F.; Steere, Allen C. (1990). "Chronic Neurologic Manifestations of Lyme Disease". New England Journal of Medicine. 323 (21): 1438–1444. doi:10.1056/NEJM199011223232102. ISSN 0028-4793.
- ↑ Fallon BA, Nields JA (1994). "Lyme disease: a neuropsychiatric illness". The American journal of psychiatry. 151 (11): 1571–83. PMID 7943444.Hess A, Buchmann J, Zettl UK; et al. (1999). "Borrelia burgdorferi central nervous system infection presenting as an organic schizophrenialike disorder". Biol. Psychiatry. 45 (6): 795. PMID 10188012. )
- ↑ Ciesielski CA, Markowitz LE, Horsley R, Hightower AW, Russell H, Broome CV (1989). "Lyme disease surveillance in the United States, 1983-1986". Rev. Infect. Dis. 11 Suppl 6: S1435–41. PMID 2682955.
- ↑ Stanek G, Strle F (2008). "Lyme disease: European perspective". Infect Dis Clin North Am. 22 (2): 327–39, vii. doi:10.1016/j.idc.2008.01.001. PMID 18452805.
- ↑ 18.0 18.1 Feder HM, Abeles M, Bernstein M, Whitaker-Worth D, Grant-Kels JM (2006). "Diagnosis, treatment, and prognosis of erythema migrans and Lyme arthritis". Clin Dermatol. 24 (6): 509–20. doi:10.1016/j.clindermatol.2006.07.012. PMID 17113969.
- ↑ Smith RP, Schoen RT, Rahn DW, Sikand VK, Nowakowski J, Parenti DL; et al. (2002). "Clinical characteristics and treatment outcome of early Lyme disease in patients with microbiologically confirmed erythema migrans". Ann Intern Med. 136 (6): 421–8. PMID 11900494.
- ↑ Edlow JA (2002). "Erythema migrans". Med Clin North Am. 86 (2): 239–60. PMID 11982300.
- ↑ Weber K, Wilske B (2006). "Mini erythema migrans--a sign of early Lyme borreliosis". Dermatology. 212 (2): 113–6. doi:10.1159/000090650. PMID 16484816.
- ↑ "Dermatology Atlas".
- ↑ Hu LT (2012). "In the clinic. Lyme disease". Ann Intern Med. 157 (3): ITC2-2–ITC2-16. doi:10.7326/0003-4819-157-3-20120807-01002. PMID 22868858.
- ↑ 24.0 24.1 Steere, Allen C. (1989). "Lyme Disease". New England Journal of Medicine. 321 (9): 586–596. doi:10.1056/NEJM198908313210906. ISSN 0028-4793.
- ↑ Fish, Airley E.; Pride, Yuri B.; Pinto, Duane S. (2008). "Lyme Carditis". Infectious Disease Clinics of North America. 22 (2): 275–288. doi:10.1016/j.idc.2007.12.008. ISSN 0891-5520.